Journal Paper
Year Paper Title
2022 陳明吉;蔡怡純, 2022.12, '建構台灣房價風險值量化評估模型, ' 中央銀行季刊, Vol.44, No.4, pp.13-53., vol. 439288, Dec. 2022
2022 Konan Chan;Re-Jin Guo;Yanzhi Wang;Hsiao-Lin Yang, 2022.12, 'Organization Capital and Analyst Coverage, ' Journal of Empirical Finance (國科會財務類A tier 1期刊), Vol.69, pp.81-105.(SSCI), vol. 439551, Dec. 2022
2022 張瑜倩*;曾信傑, 2022.12, '後疫情時代的博物館行銷, ' 博物館與文化, Vol.24, pp.1-4.(*為通訊作者), vol. 106892, Dec. 2022
2022 陳冠潔*;張興華, 2022.12, '日本純網路銀行與傳統銀行之效率與生產力分析, ' 應用經濟論叢, No.112, pp.125-170.(TSSCI)(*為通訊作者), vol. 107267, Dec. 2022
2022 Yei-Whei Lin*;Chien-Hsiu Lin;Chih-Nan Chen, 2022.12, 'Opportunities for Happiness and Its Determinants Among Children in China: A Study of Three Waves of the China Family Panel Studies Survey, ' Child Indicators Research, pp.N/A.(SSCI)(*為通訊作者), vol. 103743, Dec. 2022
2022 梁嘉紋;吳幸蓁*;林芯妤, 2022.12, '非擔任主管職務之全時員工薪資與企業揭露員工薪資調整情形之關聯性研究, ' 會計審計論叢, Vol.12, No.2, pp.87-138.(TSSCI, 獲第十四屆聯電經營管理論文獎優等獎)(*為通訊作者), vol. 104591, Dec. 2022
2022 Po-Hsuan Hsu;Hsiao-Hui Lee*;Tong Zhou, 2022.11, 'Patent Thickets, Stock Returns, and Conditional CAPM, ' Management Science, Vol.68, No.11, pp.8343-8367.(SSCI)(*為通訊作者), vol. 434433, Nov. 2022
2022 Ping-Hsun Chen*, 2022.10, 'How a Dosage Regimen Patent for RRMS Treatment May Satisfy the Written Description Requirement—A Lesson from Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc., ' Biotechnology Law Report, Vol.41, No.5, pp.240-250.(SCIE)(*為通訊作者), vol. 440831, Oct. 2022
2022 Yuan‑Horng Yan;Elizabeth P. Chou*;Ting-Bin Chen;Chun-Pai Yang;I-Ju Tsai,;Hwa-Lung Yu;Yuh-Shen Wu;Winn-Jung Huang;Shih-Ting Tseng;Tzu-Yu Peng, 2022.10, 'Long-term exposure to particulate matter was associated with increased dementia risk using both traditional approaches and novel machine learning methods, ' Scientific Reports, Vol.12, No.17130, pp.online.(SCIE)(*為通訊作者), vol. 440774, Oct. 2022
2022 楊茜文;朱芳妮;呂少毫;陳明吉, 2022.10, '房市參與者之關注會影響房價嗎？, ' 管理與系統, Vol.29, No.4, pp.495-523.(TSSCI), vol. 432840, Oct. 2022